CAPR
CAPRICOR THERAPEUTICS, INC. · Healthcare · Market cap $546.5M
Insiders sold $3.3M net in the last 90 days ·3 sellers, 0 buyers· 9 of 9 sales under Rule 10b5-1 plans· latest Form 4 filed Jun 30, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.4M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Jun 30, 2026
Krasney Karen
CAPRICOR THERAPEUTICS, INC. (CAPR) has 14 SEC Form 4 filings (32 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 30, 2026.
Inside the rolling window, 3 insiders at CAPRICOR THERAPEUTICS, INC. reported no open-market purchases and 13 open-market sales totaling $8.4M. The most active filer is EVP, GENERAL COUNSEL Krasney Karen with 5 filings. Insiders have net sold $8.4M over the trailing 6 months. The most recent open-market filing is a sale of 24,100 shares by EVP, GENERAL COUNSEL Krasney Karen, dated Jun 25, 2026, worth $732K.
- Industry:Biotechnology
- CEO:Linda Marbán
- Employees:231
- HQ:San Diego, CA, US
- IPO:2007-02-13
| Source | |||||||
|---|---|---|---|---|---|---|---|
| EVP, GENERAL COUNSEL | Sale | 24,100 | $732K | Jun 30 | -61.0% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 24,100 | $732K | Jun 30 | -61.0% | SEC ↗ | |
| EVP, GENERAL COUNSEL | Sale | 500 | $15K | Jun 25 | -69.1% | SEC ↗ | |
| EVP, GENERAL COUNSEL | Sale | 400 | $12K | Jun 25 | -69.1% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 500 | $15K | Jun 25 | -69.1% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 400 | $12K | Jun 25 | -69.1% | SEC ↗ | |
| EVP, GENERAL COUNSEL | Sale | 25,000 | $793K | May 4 | -71.9% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 25,000 | $793K | May 4 | -71.9% | SEC ↗ | |
| Director | Sale | 7,529 | $241K | Apr 3 | -70.3% | SEC ↗ | |
Krasney KarenFirst filing | EVP, GENERAL COUNSEL | Sale | 25,000 | $753K | Apr 1 | -68.8% | SEC ↗ |
Sabar Karimah EsFirst filing | Director | Sale | 61,265 | $1.8M | Apr 1 | — | SEC ↗ |
Sabar Karimah EsFirst filing | Director | Sale | 53,735 | $1.7M | Apr 1 | — | SEC ↗ |
Bergmann AnthonyFirst filing | CHIEF FINANCIAL OFFICER | Sale | 25,000 | $753K | Apr 1 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does CAPR have?
CAPRICOR THERAPEUTICS, INC. (CAPR) has 14 SEC Form 4 filings (32 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Jun 30, 2026.
When was the most recent SEC Form 4 filing for CAPR?
The most recent Form 4 filing for CAPR on Tracefour is dated Jun 30, 2026.
Who is the most active insider at CAPR?
The most active SEC Form 4 filer at CAPR in the rolling window is EVP, GENERAL COUNSEL Krasney Karen, with 5 filings.
What is the net insider flow at CAPR over the last 6 months?
Over the trailing 180 days, insiders at CAPR have net sold $8.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CAPR in the current window?
Inside the rolling window, insiders at CAPR bought $0 and sold $8.4M based on SEC Form 4 filings.
Can I get alerts for CAPR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at CAPRICOR THERAPEUTICS, INC. (CAPR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
CAPRICOR THERAPEUTICS, INC. is in the Healthcare sector.